Search results for "Union"

showing 10 items of 2069 documents

Bladder cancer index: cross-cultural adaptation into Spanish and psychometric evaluation.

2014

Background: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladder cancer patients, independent of tumor infiltration or treatment applied. We developed a Spanish version of the BCI, and assessed its acceptability and metric properties. Methods: For the adaptation into Spanish we used the forward and back-translation method, expert panels, and cognitive debriefing patient interviews. For the assessment of metric properties we used data from 197 bladder cancer patients from a multi-center prospective study. The Spanish BCI and the SF-36 Health Survey were self-administered before and 12 months after treatment. Reliability was estimated by Cronbach’s alpha.…

MalePsychometricsAparell urinariSurveys and QuestionnairesProspective cohort studyCàncermedia_commonLanguageCognitionGeneral MedicinePatient outcomeControl de qualitatNeoplasias de la Vejiga UrinariaEstudios de ValidaciónPsicometríaBufeta -- CàncerFemalePsicometriaClinical psychologyCross-Cultural ComparisonQuality of lifemedicine.medical_specialtyPsychometricsUrinary bladder neoplasms:Psychiatry and Psychology::Behavioral Disciplines and Activities::Psychological Tests::Psychometrics [Medical Subject Headings]:Publication Characteristics::Study Characteristics::Validation Studies [Medical Subject Headings]Cronbach's alpha:Disciplines and Occupations::Social Sciences::Quality of Life [Medical Subject Headings]medicine:Diseases::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Urinary Bladder Neoplasms [Medical Subject Headings]media_common.cataloged_instanceHumansEuropean UnionEuropean unionAgedNeoplasm StagingGynecologyAnalysis of VarianceBladder cancerbusiness.industryResearchPublic Health Environmental and Occupational HealthConstruct validityTranslatingmedicine.diseaseCross-cultural studiesUnited StatesValidation studiesPatient outcomesCalidad de VidabusinessHealth and quality of life outcomes
researchProduct

Short Index of Job Satisfaction: Validity evidence from Portugal and Brazil

2020

Job satisfaction is an important construct that is known to be associated with workers' performance and wellbeing. As such, to properly measure it, one must use adapted measures that show adequate validity evidence for the desired context. Such measures should preferably be short to allow the parsimonious use of various measures/constructs in the same data collection. The aim of this paper is to adapt the Portuguese version for Brazil and Portugal of the Short Index of Job Satisfaction (SIJS). The SIJS is a psychometric instrument that measures job satisfaction through five items. A cross-sectional study was conducted with two multi-occupational workers samples, one from Brazil (n = 599) an…

MalePsychometricsEconomicsEmotionsApplied psychologySocial Sciences050109 social psychologyPersonal SatisfactionBurnoutGeographical locationsSurveys and QuestionnairesMedicine and Health SciencesPsychologyBurnout ProfessionalReliability (statistics)MultidisciplinaryQ05 social sciencesRMiddle AgedEuropeProfessionsMedicineFemaleJob satisfactionPsychologyBrazilResearch ArticleEmploymentAdultPsychometricsSciencePolitical SciencePsychological StressContext (language use)JobsJob SatisfactionMental Health and Psychiatry0502 economics and businessHumans0501 psychology and cognitive sciencesMeasurement invarianceEuropean UnionLabor StudiesData collectionPortugalWork engagementBiology and Life SciencesReproducibility of ResultsSouth AmericaCross-Sectional StudiesLabor EconomicsPopulation GroupingsPeople and places050203 business & managementPLOS ONE
researchProduct

Non-readmission decisions in the intensive care unit under French rules: A nationwide survey of practices.

2018

International audience; Purpose: We investigated, using a multicentre survey of practices in France, the practices of ICU physicians concerning the decision not to readmit to the ICU, in light of current legislation.Materials and methods: Multicentre survey of practices among French ICU physicians via electronic questionnaire in January 2016. Questions related to respondents’ practices regarding re-admission of patients to the ICU and how these decisions were made. Criteria were evaluated by the health care professionals as regards importance for non-readmission.Results: In total, 167 physicians agreed to participate, of whom 165 (99%) actually returned a completed questionnaire from 58 ICU…

MaleQuestionnairesMedical DoctorsHealth Care Providerslcsh:MedicineSocial SciencesNationwide surveyGeographical locationslaw.invention0302 clinical medicineCognitionlawSurveys and QuestionnairesHealth careMedicine and Health SciencesMedicinePsychology030212 general & internal medicineMedical PersonnelPractice Patterns Physicians'lcsh:ScienceMultidisciplinary[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyPalliative CareMiddle AgedTime optimalIntensive care unitHospitals3. Good healthEuropeIntensive Care UnitsProfessionsResearch DesignFemaleFranceResearch ArticleAdultmedicine.medical_specialtyCritical CareClinical Decision-MakingDecision MakingMEDLINELegislationResearch and Analysis MethodsPatient Readmission03 medical and health sciencesGeneral PractitionersPhysiciansHumansFamilyEuropean UnionSurvey Researchbusiness.industrylcsh:RCognitive PsychologyBiology and Life Sciences030208 emergency & critical care medicineHealth CareMulticenter study[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieHealth Care FacilitiesFamily medicinePeople and PlacesCognitive Sciencelcsh:Q[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiePopulation GroupingsPatient ParticipationbusinessHealthcare providers[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyNeurosciencePloS one
researchProduct

A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area

2020

Background Data on the true prevalence of hepatitis C virus (HCV) infection in the general population is essential. We evaluated a program implementing free universal HCV screening using a non-invasive point-of-care test (POCT) (OraQuick-HCV rapid test) in oral fluid in an urban area in Valencia, South-Eastern Spain. Methods A cross-sectional study was performed during 2015–2017. Free HCV screening was offered by regular mail to 11,500 individuals aged 18 and over, randomly selected from all census residents in the Health Department. All responding participants filled in a questionnaire about HCV infection risk factors and were tested in their tertiary Hospital. In those with a positive POC…

MaleRNA virusesSustained Virologic ResponseUrban PopulationEpidemiologyPhysiologyCross-sectional studyHepacivirusmedicine.disease_causeBiochemistryGeographical locations0302 clinical medicineRisk FactorsImmune PhysiologyPrevalence030212 general & internal medicineEnzyme-Linked ImmunoassaysYoung adultPathology and laboratory medicineAged 80 and overResponse rate (survey)education.field_of_studyImmune System ProteinsMultidisciplinaryHepatitis C virusQRMiddle AgedMedical microbiologyHepatitis CEuropeVirusesRNA ViralMedicineFemale030211 gastroenterology & hepatologyStandardized ratePathogensResearch ArticleAdultmedicine.medical_specialtyAdolescentPoint-of-Care SystemsScienceHepatitis C virusPoint-of-care testingImmunologyPopulationResearch and Analysis MethodsAntiviral AgentsMicrobiologyAntibodiesYoung Adult03 medical and health sciencesInternal medicinemedicineHumansEuropean UnionRisk factorImmunoassayseducationAgedMedicine and health sciencesBiology and life sciencesFlavivirusesbusiness.industryOrganismsViral pathogensProteinsHepatitis C AntibodiesFibrosisHepatitis virusesMicrobial pathogensHealth CareCross-Sectional StudiesSpainMedical Risk FactorsImmunologic TechniquesInterferonsPeople and placesbusinessDevelopmental BiologyPLOS ONE
researchProduct

Regulatory and academic studies to derive reference values for human health: The case of bisphenol S

2022

We would like to thank the HBM4EU team including Petra Apel (UBA), Matthieu Meslin and Christophe Rousselle (Anses) for their scientific contribution, as well as the ANSES Working Group on endocrine disruption, and its scientific Anses coordinators François Pouzaud and Sandrine Charles.; International audience; The close structural analogy of bisphenol (BP) S with BPA, a recognized endocrine-disrupting chemical and a substance of very high concern in the European Union, highlights the need to assess the extent of similarities between the two compounds and carefully scrutinize BPS potential toxicity for human health. This analysis aimed to investigate human health toxicity data regarding BPS…

MaleSwineBisphenol SPhysiologyBiological Availability010501 environmental sciencesBiologyEndocrine Disruptors01 natural sciencesBiochemistry03 medical and health scienceschemistry.chemical_compoundHuman healthPhenolsReference ValuesMESH: Policy MakingPolicy makingmedia_common.cataloged_instanceAnimalsHumansSulfonesEuropean unionBenzhydryl Compounds030304 developmental biology0105 earth and related environmental sciencesGeneral Environmental Sciencemedia_common0303 health sciencesPotential impactToxicity3. Good healthBioavailabilityMESH: Endocrine Disruptors[SDV.TOX] Life Sciences [q-bio]/ToxicologyBisphenol SchemistryReference values[SDV.TOX]Life Sciences [q-bio]/ToxicologyToxicityHealth-based guidance valueFemaleEndocrine-disrupting chemicalTarget organhormones hormone substitutes and hormone antagonists
researchProduct

Changes in disease burden in Poland between 1990-2017 in comparison with other Central European countries: A systematic analysis for the Global Burde…

2020

Background Systematic collection of mortality/morbidity data over time is crucial for monitoring trends in population health, developing health policies, assessing the impact of health programs. In Poland, a comprehensive analysis describing trends in disease burden for major conditions has never been published. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides data on the burden of over 300 diseases in 195 countries since 1990. We used the GBD database to undertake an assessment of disease burden in Poland, evaluate changes in population health between 1990–2017, and compare Poland with other Central European (CE) countries. Methods The results of GBD 2017 for …

MaleSystems AnalysisPulmonology030204 cardiovascular system & hematologyGlobal HealthPathology and Laboratory MedicineGeographical locationsGlobal Burden of DiseaseSelf Harm0302 clinical medicineEndocrinologySex factorsRisk FactorsGlobal healthMedicine and Health SciencesMedicinePublic and Occupational Health030212 general & internal medicineChild2. Zero hungerAged 80 and overMultidisciplinaryOrganic CompoundsQ1. No povertyRMiddle Aged3. Good healthEuropeChemistryChild PreschoolPhysical SciencesMedicineFemaleQuality-Adjusted Life YearsResearch ArticleBurden of diseaseAdultCross-Cultural ComparisonAdolescentEndocrine DisordersChronic Obstructive Pulmonary DiseaseScienceLower Back PainMEDLINEPainPopulation health03 medical and health sciencesYoung AdultSigns and SymptomsLife ExpectancySex FactorsDiagnostic MedicineEnvironmental healthburden of disease Poland epidemiologyMental Health and PsychiatryDiabetes MellitusHumansEuropean UnionDisease burdenAgedbusiness.industryMortality PrematureOrganic ChemistryChemical CompoundsInfant NewbornInfantQuality-adjusted life yearAlcoholsMetabolic DisordersPolandPeople and placesbusinessPLoS ONE
researchProduct

Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma

2018

Temsirolimus 175 mg once-weekly for 3 weeks, followed by 75 mg once-weekly intravenously dosed (175/75 mg) is approved in the European Union for treatment of relapsed/refractory mantle cell lymphoma (MCL). A phase IV study explored whether similar efficacy, but improved safety could be achieved with 75 mg without 175 mg loading doses (ClinicaTrials.gov: NCT01180049). Patients with relapsed/refractory MCL were randomized to once-weekly temsirolimus 175/75 mg (n = 47) or 75 mg (n = 42). Treatment continued until objective disease progression. Primary endpoint: progression-free survival (PFS). Secondary endpoints included overall survival (OS) and adverse events (AEs). Median PFS was 4.3 versu…

MaleTemsirolimusCancer ResearchLymphomaDrug ResistanceLymphoma Mantle-CellGastroenterology0302 clinical medicineAntineoplastic Combined Chemotherapy Protocols80 and overClinical endpointmedia_commonAged 80 and overHazard ratioHematologyMiddle AgedPrognosisTemsirolimusSurvival RateLocalOncology030220 oncology & carcinogenesisInjections IntravenousRefractory Mantle Cell LymphomaFemaleIntravenousmedicine.drugsafetymedicine.medical_specialtyoverall survivalmantle cell lymphomaAntineoplastic AgentsDrug Administration ScheduleInjections03 medical and health sciencesRefractoryInternal medicinemedicineHumansmedia_common.cataloged_instanceProgression-free survivalEuropean unionAgedSirolimusSalvage Therapybusiness.industryMantle-Cellmedicine.diseaseSurgeryNeoplasm RecurrenceDrug Resistance NeoplasmNeoplasmMantle cell lymphomaNeoplasm Recurrence Localbusinessprogression-free survivalFollow-Up Studies030215 immunology
researchProduct

Factor structure and measurement invariance across various demographic groups and over time for the phq-9 in primary care patients in spain

2018

The Patient Health Questionnaire (PHQ-9) is a widely-used screening tool for depression in primary care settings. The purpose of the present study is to identify the factor structure of the PHQ-9 and to examine the measurement invariance of this instrument across different sociodemographic groups and over time in a sample of primary care patients in Spain. Data came from 836 primary care patients enrolled in a randomized controlled trial (PsicAP study) and a subsample of 218 patients who participated in a follow-up assessment at 3 months. Confirmatory factor analysis (CFA) was used to test one- and two-factor structures identified in previous studies. Analyses of multiple-group invariance w…

MaleTime FactorsEconomicsEmotionsMedizinSocial Scienceslcsh:MedicinePatient Health QuestionnaireGeographical locationslaw.invention0302 clinical medicineMathematical and Statistical TechniquesRandomized controlled triallawMedicine and Health SciencesMedicinePsychologyYoung adultlcsh:ScienceDepression (differential diagnoses)MultidisciplinaryPharmaceuticsDepressionMiddle AgedConfirmatory factor analysisTest (assessment)EuropePhysical SciencesMarital statusPsicometríaFemaleFactor AnalysisStatistics (Mathematics)Research ArticleEmploymentAdultAdolescentResearch and Analysis Methods03 medical and health sciencesYoung AdultDrug TherapyDiagnostic MedicineMental Health and PsychiatryHumansMeasurement invarianceEuropean UnionStatistical MethodsPrimary CarePrimary Health Carebusiness.industryMood Disorderslcsh:RBiology and Life Sciences030227 psychiatryPatient Health QuestionnaireHealth CarePsychologieSocioeconomic FactorsPsicologiaSpainLabor Economicslcsh:QPeople and placesbusinessFactor Analysis Statistical030217 neurology & neurosurgeryMathematicsDemography
researchProduct

Drivers and Social Implications of Artificial Intelligence Adoption in Healthcare during the COVID-19 Pandemic

2021

The COVID-19 pandemic continues to impact people worldwide–steadily depleting scarce resources in healthcare. Medical Artificial Intelligence (AI) promises a much-needed relief but only if the technology gets adopted at scale. The present research investigates people’s intention to adopt medical AI as well as the drivers of this adoption in a representative study of two European countries (Denmark and France,N= 1068) during the initial phase of the COVID-19 pandemic. Results reveal AI aversion; only 1 of 10 individuals choose medical AI over human physicians in a hypothetical triage-phase of COVID-19 pre-hospital entrance. Key predictors of medical AI adoption are people’s trust in medical …

MaleViral DiseasesEpidemiologyHealth Care ProvidersDenmarkSELF-ESTEEMIntelligenceSocial SciencesmedicalGeographical locationsCovidMedical ConditionsPandemicHealth careMedicine and Health SciencesPsychologyMedical Personneladoptionmedia_commonMultidisciplinaryQRhealthcareCovid19healthdriversMiddle Aged[SHS.ECO]Humanities and Social Sciences/Economics and FinanceTelemedicinedoctorEuropeProfessionsInfectious DiseasesdataScale (social sciences)HumanityArtificialTraitMedicineFemaleFrancePsychologyCovid-19Research ArticlePersonalityAdultComputer and Information Sciencesmedia_common.quotation_subjectScienceMEDLINENeglectScarcityPSYCHOLOGYPEOPLEArtificial IntelligencePhysiciansHumansEuropean UnionPandemicsAgedPersonality Traitsbusiness.industrypandemicBiology and Life SciencesCovid 19socialimplicationsHealth CareAttitudeSocioeconomic FactorsAIPeople and PlacesPopulation GroupingsArtificial intelligencebusiness
researchProduct

2011–12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hos…

2013

BackgroundInfluenza vaccination strategies aim at protecting high-risk population from severe outcomes. Estimating the effectiveness of seasonal vaccines against influenza related hospitalisation is important to guide these strategies. Large sample size is needed to have precise estimate of influenza vaccine effectiveness (IVE) against severe outcomes. We assessed the feasibility of measuring seasonal IVE against hospitalisation with laboratory confirmed influenza through a network of 21 hospitals in the European Union.MethodsWe conducted a multicentre study in France (seven hospitals), Italy (one hospital), and Navarra (four hospitals) and Valencia (nine hospitals) regions in Spain. All ≥1…

MaleViral DiseasesEpidemiologyPilot ProjectsLogistic regressionmedicine.disease_cause0302 clinical medicineInfluenza A virusClinical Epidemiology030212 general & internal medicineEpidemiological Methodsmedia_commonAged 80 and overeducation.field_of_studyVaccinesMultidisciplinaryQVaccinationREpidemiology of AgingMiddle Aged3. Good healthVaccinationHospitalizationInfectious DiseasesInfluenza VaccinesMedicineFemaleSeasonsResearch ArticleAdultmedicine.medical_specialtyAdolescentInfluenza vaccineClinical Research DesignScience030231 tropical medicinePopulationMicrobiologyHistory 21st CenturyInfectious Disease Epidemiology03 medical and health sciencesYoung AdultInternal medicineVirologyVaccine DevelopmentInfluenza Humanmedicinemedia_common.cataloged_instanceHumansEuropean UnionEuropean unioneducationBiologyAgedbusiness.industryInfluenza A Virus H3N2 SubtypeCase-control studyImmunityViral VaccinesInfluenzaSample size determinationCase-Control StudiesImmunologyClinical ImmunologybusinessPLoS ONE
researchProduct